CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024

CS MEDICA has chosen to delay the release of its Annual Report to Wednesday, February 14, 2024.  Subsequently, the Annual General Meeting has been moved to Thursday, February 29, 2024.

CS MEDICA A/S, a MedTech company that focuses on treating pain, autoimmune diseases, and stress-related disorders with therapeutic CBD/cannabinoids, announces the rescheduling of its Annual Report to Wednesday, February 14, 2024. Consequently, the Annual General Meeting is also rescheduled and will now occur on Thursday, February 29, 2024.